Log in  First Connection?

Acute & Chronic Kidney InjuryArchives

Structural and functional capillary integrity, arterial stiffness and central hemodynamics in CKD patients with and without nocturnal hypertension

 Published on 02/07/2025 |  Original article (Full-text)  | Marieta P Theodorakopoulou et al. | American Journal of Hypertension 2025; aop: 10.1093/ajh/hpaf043

This content is only available as a PDF....

AKI in ACLF: navigating the complex therapeutic puzzle

 Published on 25/06/2025 |  Original article (Full-text)  | Rakhi Maiwall et al. | Expert Review of Gastroenterology & Hepatology 2025; 19(2): 165-80

Acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) is driven by the severity of systemic inflammation, acute portal hypertension driving circulatory dysfunction, hyperbilirubinemia, and toxicity of bile acids. The spectrum is mostly structural, associated with reduced response...

The role of amino acids and protein administration in preventing cardiac surgery-associated acute kidney injury

 Published on 18/06/2025 |  Original article (Full-text)  | Alice Bottussi et al. | Future Cardiology 2025; 21(3): 191-202

Acute kidney injury (AKI) persists as one of the most common complications after cardiac surgery. Beyond being burdened by high morbidity and mortality rates, effective therapeutic options are still lacking. To date, the management of cardiac surgery-associated AKI (CSA-AKI) mainly focuses on preventive...

Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients

 Published on 11/06/2025 |  Original article (Full-text)  | Wei-Ying Jen a et al. | Leukemia & Lymphoma 2024; 65(3): 378-82

Arsenic trioxide (ATO)-based regimens are standard in acute promyelocytic leukemia (APL). ATO-related nephrotoxicity has not been reported. We reviewed APL patients treated with ATO to identify cases of acute kidney injury (AKI). Clinically significant cases were characterized. Multivariate analysis...